Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

Fig. 5

Markers levels on patients after 6 months semaglutide treatment. A Volcano plot represents the fold change of main markers levels on patients with cardiovascular disease after semaglutide treatment. B STRING Network among analysed biomarkers on treated patients with semaglutide. % of patients who reduced (blue) or increased (red) markers levels: ITGAM: CD11B; NPPA: ANP; THBS2:TSP2; C5AR1: CD88; CXCL8:IL8; FCGR3A: CD16; M2: pro-inflammatory macrophages CD14+CD16+

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840